Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Counterbalancing patient demands with evidence: results from a pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosus.
Dobkin PL, Da Costa D, Joseph L, Fortin PR, Edworthy S, Barr S, Ensworth S, Esdaile JM, Beaulieu A, Zummer M, Senécal JL, Goulet JR, Choquette D, Rich E, Smith D, Cividino A, Gladman D, St-Pierre Y, Clarke AE. Dobkin PL, et al. Among authors: goulet jr. Ann Behav Med. 2002 Spring;24(2):88-99. doi: 10.1207/S15324796ABM2402_05. Ann Behav Med. 2002. PMID: 12054324 Clinical Trial.
Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival.
Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR, Raymond Y, Senécal JL. Scussel-Lonzetti L, et al. Among authors: goulet jr. Medicine (Baltimore). 2002 Mar;81(2):154-67. doi: 10.1097/00005792-200203000-00005. Medicine (Baltimore). 2002. PMID: 11889414 Free article. No abstract available.
Group psychotherapy reduces illness intrusiveness in systemic lupus erythematosus.
Edworthy SM, Dobkin PL, Clarke AE, Da Costa D, Dritsa M, Fortin PR, Barr S, Ensworth S, Esdaile JM, Beaulieu A, Zummer M, Senécal JL, Goulet JR, Choquette D, Rich E, Smith D, Cividino A, Gladman D, Devins GM. Edworthy SM, et al. Among authors: goulet jr. J Rheumatol. 2003 May;30(5):1011-6. J Rheumatol. 2003. PMID: 12734897 Clinical Trial.
The systemic lupus erythematosus Tri-Nation study: cumulative indirect costs.
Panopalis P, Petri M, Manzi S, Isenberg DA, Gordon C, Senécal JL, Penrod JR, Joseph L, St Pierre Y, Pineau C, Fortin PR, Sutcliffe N, Goulet JR, Choquette D, Grodzicky T, Esdaile JM, Clarke AE; Tri-Nation Study Group. Panopalis P, et al. Among authors: goulet jr. Arthritis Rheum. 2007 Feb 15;57(1):64-70. doi: 10.1002/art.22470. Arthritis Rheum. 2007. PMID: 17266095 Free article.
Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, Goulet JR, Rich E, Grodzicky T, Raymond Y, Senécal JL. Koenig M, et al. Among authors: goulet jr. Arthritis Rheum. 2008 Dec;58(12):3902-12. doi: 10.1002/art.24038. Arthritis Rheum. 2008. PMID: 19035499 Free article.
Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Troyanov Y, Targoff IN, Payette MP, Raynauld JP, Chartier S, Goulet JR, Bourré-Tessier J, Rich E, Grodzicky T, Fritzler MJ, Joyal F, Koenig M, Senécal JL. Troyanov Y, et al. Among authors: goulet jr. Medicine (Baltimore). 2014 Nov;93(24):318-332. doi: 10.1097/MD.0000000000000222. Medicine (Baltimore). 2014. PMID: 25500701 Free PMC article.
Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype.
Troyanov Y, Landon-Cardinal O, Fritzler MJ, Ferreira J, Targoff IN, Rich E, Goulet M, Goulet JR, Bourré-Tessier J, Robitaille Y, Drouin J, Albert A, Senécal JL. Troyanov Y, et al. Among authors: goulet jr. Medicine (Baltimore). 2017 Jan;96(3):e5694. doi: 10.1097/MD.0000000000005694. Medicine (Baltimore). 2017. PMID: 28099331 Free PMC article.
Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies.
Landon-Cardinal O, Baril-Dionne A, Hoa S, Meyer A, Leclair V, Bourré-Tessier J, Mansour AM, Zarka F, Makhzoum JP, Nehme J, Rich E, Goulet JR, Grodzicky T, Koenig M, Joyal F, Richard I, Hudson M, Targoff I, Satoh M, Fritzler MJ, Troyanov Y, Senécal JL. Landon-Cardinal O, et al. Among authors: goulet jr. RMD Open. 2020 Sep;6(2):e001357. doi: 10.1136/rmdopen-2020-001357. RMD Open. 2020. PMID: 32892170 Free PMC article.
Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotype.
El Kamouni H, S Jalaledin D, Albert A, Hoa S, Vo C, Bourré-Tessier J, Rich É, Goulet JR, Koenig M, Pérez G, Choi MY, Troyanov Y, Satoh M, Fritzler MJ, Senécal JL, Landon-Cardinal O. El Kamouni H, et al. Among authors: goulet jr. RMD Open. 2023 Oct;9(4):e003431. doi: 10.1136/rmdopen-2023-003431. RMD Open. 2023. PMID: 37797966 Free PMC article.
68 results